Requip and Bundle branch block left - a phase IV clinical study of FDA data

Summary:

Bundle branch block left is reported as a side effect among people who take Requip (ropinirole hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Spironolactone, and have Metastases to spine.

The phase IV clinical study analyzes which people have Bundle branch block left when taking Requip. It is created by eHealthMe based on reports of 21,866 people who have side effects when taking Requip from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Bundle branch block left?

Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle) is found to be associated with 731 drugs and 793 conditions by eHealthMe. Check the latest studies of Bundle branch block left.

On Jul, 09, 2026

21,866 people reported to have side effects when taking Requip.
Among them, 17 people (0.08%) have Bundle branch block left.

Could Requip cause Bundle branch block left?

Among these 17 people:

How long have people been on Requip when they have Bundle branch block left? *

What is the gender of people who have Bundle branch block left when taking Requip? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Bundle branch block left when taking Requip? *

What are other drugs people take besides Requip? *

What are other side effects people have besides Bundle branch block left? *

Dyspnea (difficult or laboured breathing): 17 people, 100.00%
Pain: 15 people, 88.24%
Mitral Valve Incompetence (inefficient heart valve): 15 people, 88.24%
Depression: 14 people, 82.35%
Stress And Anxiety: 14 people, 82.35%
Weakness: 13 people, 76.47%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 76.47%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 76.47%
Headache (pain in head): 13 people, 76.47%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 12 people, 70.59%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 9 people, 52.94%
Calcium Deficiency (lack of calcium): 9 people, 52.94%
Metastases To Spine (cancer spreads to spine): 9 people, 52.94%
Lung Neoplasm (tumour of lung): 8 people, 47.06%
Breast Cancer: 2 people, 11.76%
Metastases To Bone (cancer spreads to bone): 2 people, 11.76%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 5.88%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%
Arrhythmias (irregular heartbeat): 1 person, 5.88%
Cardiac Failure Congestive: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and have Bundle branch block left?

- Check whether Bundle branch block left is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Requip:

Requip (22,950 reports)

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bundle branch block left:

Bundle branch block left (731 drugs)

Browse all the conditions that are associated with Bundle branch block left:

Bundle branch block left (793 conditions)

Related publications that referenced our studies

Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride (the active ingredients of Requip) and Requip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.